MolNFT v1 · #136892 · protein
Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-{[2-(4-chlorophenyl)-2-OXOETHYL]SULFANYL}BENZOIC acid
5V6Z: “Crystal structure of human caspase-7 soaked with allosteric inhibitor…”. X-ray diffraction, 1 ligand (8YJ), 2 pockets (best druggability 0.58). MolNFT v1 #136892 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5V6Z
- Type
- protein
- Length
- 411 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Caspase-7
- EC
- 3.4.22.60
- UniProt
- P55210
- Ligands
- 8YJ
- Pockets
- 2 · best druggability 0.58
Structure
x-ray diffraction · 2 distinct chains · 34% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Caspase-7 (EC 3.4.22.60) | protein | 201 | 32% helix, 27% strand | P55210 |
| B | Caspase-7 (EC 3.4.22.60) | protein | 210 | 35% helix, 26% strand | P55210 |
Ligands and binding sites
- 8YJ · 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid · ligand · chains B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 362 | 0.58 | 0.75 | 51 | 8YJ |
| 2 | 71 | 0.38 | 0.78 | 25 | empty |
Interfaces
1 interface between chains.
- A–B · 1154 Ų buried · 16 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 1 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P55210
- Elsewhere: RCSB PDB 5V6Z · PDBe 5V6Z · UniProt P55210
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.